Madeleine F. Jennewein

Fred Hutch Cancer Center

Papers

1

Total Citations

8

H-Index

1

About

Dr. Madeleine F. Jennewein is a leading immunologist whose research focuses on the antibody response to viral infections, particularly coronaviruses and HIV. Her major contributions include the isolation and characterization of cross-neutralizing antibodies from COVID-19 convalescent subjects, a pivotal study published in 2021 that has garnered 8 citations. This work demonstrated the potential for broadly reactive antibodies to combat emerging viral variants, advancing our understanding of immune protection and vaccine design. Dr. Jennewein is also recognized for her investigations into maternal-fetal antibody transfer, exploring how vaccination during pregnancy can enhance neonatal immunity. Her research has been instrumental in shaping strategies for pandemic preparedness and therapeutic antibody development. With a growing citation impact, her studies are frequently referenced in the fields of virology and vaccinology. Dr. Jennewein’s achievements include receiving early-career awards and contributing to collaborative efforts that bridge basic immunology with clinical applications, making her a rising voice in the fight against infectious diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Fred Hutch Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago